Low-Dose Naltrexone: How It Works and What Is Being Studied

Written by Evergreen Editorial, Evergreen Telehealth

Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth

Published Updated

Quick Answer

Low-dose naltrexone (LDN) is naltrexone taken at a much lower dose than the FDA-approved dose used for opioid and alcohol use disorders. (1) Using it at low doses is off-label, and the most research is in fibromyalgia, where the evidence is limited and the largest placebo-controlled trial found no pain benefit over placebo. (2, 5) Common side effects are vivid dreams and trouble sleeping, and LDN cannot be taken with opioid medicines.

A woman lying on a bed with her legs kicked up in the air, laughing in a bright bedroom with light linen bedding

Introduction

Low-dose naltrexone (LDN) is a very small dose of naltrexone, a medication originally approved at much higher doses to treat alcohol and opioid use disorders. At low doses it works differently, and clinicians have prescribed it off-label for conditions involving pain, inflammation, and fatigue. It is taken as a capsule at bedtime, with no needles involved.

The honest summary: LDN has real research behind it in some areas, most notably fibromyalgia, but the evidence is limited, and there is no good evidence that it slows aging. This guide explains how LDN is thought to work, what has been studied, what side effects to expect, and who should not take it.

What Is Low-Dose Naltrexone?

Naltrexone is an FDA-approved medication for alcohol use disorder and opioid dependence, typically at doses of 50 mg or more. (1) "Low-dose" naltrexone usually refers to doses roughly ten times smaller, traditionally in the range of 1 to 5 mg, though some clinical studies have used up to about 6 mg. (2) Your exact dose is personal to you, set by your prescriber, and lives in your plan rather than in a general article.

Using naltrexone at these lower doses for pain or inflammation is considered off-label, meaning it is not an FDA-approved use. LDN prescribed through telehealth is typically a compounded medication, made for you by a licensed pharmacy. Compounded medicines are not FDA-approved as finished drug products. (3) Your prescribing clinician decides, based on your individual medical needs, whether a compounded medicine is appropriate.

How Does LDN Work?

At standard doses, naltrexone blocks opioid receptors for most of the day. LDN is thought to work differently. Taken at bedtime, it briefly blocks certain brain signals overnight, and the body responds by making more of its own endorphins, the natural chemicals involved in mood and pain. Researchers have also proposed that LDN calms inflammatory activity in the brain's immune cells (glia), partly through a receptor called TLR-4. (4)

These explanations are proposed mechanisms. Reviewers note that how LDN works still needs to be confirmed in human trials. (5)

What Does the Research Show?

Fibromyalgia is the best-studied use. Small randomized trials have reported less pain with LDN than with placebo, and a 2024 meta-analysis of four randomized trials (222 patients) found a statistically significant reduction in pain scores. (4) However, the largest and most rigorously designed trial, which gave 99 women 6 mg daily or placebo for 12 weeks, did not find LDN superior to placebo for pain, though it suggested a possible benefit for memory problems that needs confirming. (2) Overall, reviewers describe the overall strength of evidence as limited or low, because trials are small and short, use different doses, and have mostly enrolled women. (5) Another meta-analysis described the results as mixed. (6)

Other uses are less established. LDN has also been explored in other conditions, but the studies we reviewed were mostly small or early, and its use for them is not established. Research on LDN for weight management, energy, or healthy aging is preliminary, and we found no study showing that LDN extends lifespan or slows biological aging.

What that means for you. LDN has been studied for pain, the evidence is limited, and results vary from person to person. It is not a proven anti-aging or weight-loss treatment. A clinician should help you decide whether it makes sense for your situation.

How Is LDN Taken?

Evergreen's patient guide describes LDN as one capsule taken at bedtime, at around the same time each night. Linking it to a habit such as brushing your teeth helps with consistency. Swallow it whole with water unless your care team tells you otherwise, and store it at room temperature in a dry place, away from children and pets. It can be taken on its own or alongside a GLP-1 medication, depending on your plan.

Some people notice nothing for several weeks, and a clinician decides whether to continue. If you miss a dose, skip it and take your next capsule at bedtime, and never take two at once.

What Side Effects Can LDN Cause?

Side effects are usually mild and tend to ease within a couple of weeks. Common ones include:

  • Vivid dreams. Some people have very real dreams at first. Randomized trials have found vivid dreams more common with LDN than placebo, and this often fades within one to two weeks. (7)
  • Trouble sleeping. Let your care team know if it is hard to fall or stay asleep. Your provider may adjust your plan.
  • Headache. Usually mild and short. Drinking plenty of water can help.
  • Mild nausea. Taking your capsule with a little food may help.

Contact your care team if you feel down, if sleep problems do not improve, or if side effects last or bother you. Call 911 or go to the ER for trouble breathing, swelling of the face, lips, tongue, or throat, a rash or hives with trouble breathing, yellow skin or eyes, dark urine, or pain in the upper right belly, thoughts of harming yourself, or restlessness, sweating, stomach cramps, or flu-like feelings soon after a dose if you have taken any opioid.

Who Should Avoid LDN or Talk With a Clinician First?

  • Anyone taking opioid medicines. LDN cannot be taken with opioids, including some pain medicines, codeine cough medicines, and kratom. Tell any doctor, dentist, or ER that you take LDN so pain care can be planned safely.
  • Pregnancy or breastfeeding. LDN is not used during either.
  • Serious liver disease. LDN is not a fit with serious liver disease, and your provider may suggest a liver blood test near the start and once a year. Heavy drinking adds strain too.
  • Thyroid medicine. LDN may change how much thyroid medicine you need over time, so your provider may check your levels.

This is a general overview, not a complete list, and a clinician makes the decision for each person. Not everyone will be a candidate for LDN.

Frequently Asked Questions

Is low-dose naltrexone FDA-approved? Naltrexone itself is FDA-approved, but only at higher doses for alcohol and opioid use disorders. (1) Using it at low doses for pain, inflammation, or other goals is off-label, and compounded LDN is not FDA-approved as a finished drug.

Is LDN the same as naltrexone? It is the same medicine at a much lower dose. The lower dose is believed to act differently in the body than the standard dose used for addiction treatment.

Does LDN help with weight loss? LDN is not approved as a weight-loss medication, and high-quality evidence for weight loss is limited. LDN is offered through both programs, so you can learn more about Evergreen Longevity → or Evergreen Lean →.

Can I take LDN with a GLP-1 medication? Evergreen's patient guide says LDN can be taken on its own or along with a GLP-1. Research on the combination is limited, so your clinician should decide whether it fits your plan. For background on GLP-1 treatment, see The Complete Guide to GLP-1 Weight Loss Treatment → and What Are the Possible Side Effects of GLP-1s? →.

How long until I notice anything? Some people notice nothing for several weeks, and a clinician decides whether to continue. Check in with your care team rather than stopping on your own.

Learn More About Evergreen Longevity

LDN is one of several approaches used in longevity medicine, and any treatment plan should be individualized and monitored by a licensed clinician. For the broader picture, read The Complete Guide to Longevity Treatments and Healthy Aging →.

Explore Clinician-Guided Longevity Care. Learn how Evergreen Longevity approaches healthy aging through individualized protocols and ongoing provider monitoring. Explore Evergreen Longevity → LDN is also offered through Evergreen Lean →, Evergreen's clinician-guided weight-loss program.

Not every applicant will qualify for every treatment.

References

1. FDA-approved uses of naltrexone and LDN in fibromyalgia: Yang J, Shin KM, Do A, et al. The safety and efficacy of low-dose naltrexone in patients with fibromyalgia: a systematic review. J Pain Res. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10039621/

2. 6 mg randomized trial and dose range: Due Bruun K, Christensen R, Amris K, et al. Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2024;6:e31-e39. https://pubmed.ncbi.nlm.nih.gov/38258677/

3. Compounded drugs and FDA approval: U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

4. Meta-analysis of randomized trials and proposed mechanism: Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Korean J Pain. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11450306/ ; and Efficacy and safety of low-dose naltrexone (LDN) in fibromyalgia: a systematic review and meta-analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC12055162/

5. Strength of evidence and mechanism: A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia. https://pmc.ncbi.nlm.nih.gov/articles/PMC10189400/

6. Mixed results: Efficacy of low-dose naltrexone in treating patients with fibromyalgia: systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/40272382/

7. Vivid dreams: Efficacy and safety of low-dose naltrexone (LDN) in fibromyalgia: a systematic review and meta-analysis. https://pmc.ncbi.nlm.nih.gov/articles/PMC12055162/

This page is for educational purposes only and is not a substitute for individualized medical advice. Always consult a licensed healthcare provider before starting or stopping any medication. Information and statements on this material have not been evaluated by the Food and Drug Administration. Evergreen Telehealth content is for general education and should never replace professional medical advice that considers your individual health.

Medically reviewed by Dr. Casey Greene, PharmD, IFMCP, Peptide Subject Matter Expert, Evergreen Telehealth, on November 17, 2026.

EVERGREEN DISCLOSURE

The statements above have not been evaluated by the Food and Drug Administration. Evergreen products are not designed to diagnose, treat, cure, or prevent any medical condition. Before receiving a prescription, patients complete an online evaluation with a licensed physician. Whether a prescription is appropriate is a clinical determination made at that time. Certain products are prepared by a licensed compounding pharmacy. The FDA does not review or approve compounded formulations for safety, effectiveness, or quality. Full safety information is available on each individual product page. Any outcomes or benefits described on helloevergreen.com reflect independent, third-party research, and are not guarantees tied to Evergreen’s specific formulations unless stated otherwise. All medications are provided through a subscription model, and patients may cancel at any time prior to next refill. Product packaging received may vary from images shown on this website.